The University of Southampton
University of Southampton Institutional Repository

Risk of reoperation for structural failure of aortic and mitral tissue valves

Risk of reoperation for structural failure of aortic and mitral tissue valves
Risk of reoperation for structural failure of aortic and mitral tissue valves
In order to assess the risk of reoperation in the case of a failing stented tissue valve, 259 patients (118 males, 141 females; mean age 60.1 ± 15.4 years) underwent redo valve replacement. Of these patients, 94 (36.3%) underwent redo aortic valve replacement (AVR), 105 (40.5%) redo mitral valve replacement (MVR), and 60 (23.2%) redo aortic and mitral valve replacement (DVR). Twenty patients (7.7%) had previous coronary artery bypass grafting (CABG); further CABG were performed in 32 cases (12.4%). Preoperatively, 216 patients (83.3%) were in NYHA functional class III or IV. Early mortality was (6.5%; n = 17). A higher preoperative NHYA status (p <0.0004) and emergency surgery (p <0.0001) were associated with an increased risk of operative death. Age at operation (p = 0.45), previous CABG (p = 0.45), position of the valve replaced (p = 0.2), type of implant (p = 0.06) and presence of coronary artery disease (p = 0.51) were not associated with a significant risk of operative mortality. A failing tissue valve may be replaced, with acceptable operative mortality and morbidity. The trend towards reducing the age at which tissue valve implantation is performed may be justified.
0966-8519
419-423
Dalrymple-Hay, Malcolm J.R.
daa13255-f063-4c07-b316-9fd5687251a8
Crook, Timothy
737cb775-ff4f-48be-aad2-c8ae7e0224d1
Bannon, Paul G.
4f5e7182-7346-4f4e-810a-ab34a1b96f4b
Ohri, Sunil K.
8aa5698c-78cf-4f59-a5af-5afa46f0348c
Haw, Marcus P.
de1cf3ff-7184-4e05-af6b-5a90085a8eba
Bayfield, Matthew S.
a3ce0ced-6488-4b3c-8f90-edae9463a75c
Hendel, Nick P.
d0115d1e-a8e4-4bdb-a9ff-4c37b5919db2
Livesey, Steven A.
c5d8a3d1-266b-41a4-9165-77c02e13bc6f
Hughes, Clifford F.
256714a8-a89a-4bc5-9bbb-a74cb867a421
Monro, James L.
68cc1066-fb7a-42cb-8d14-d92ee8680ce9
Dalrymple-Hay, Malcolm J.R.
daa13255-f063-4c07-b316-9fd5687251a8
Crook, Timothy
737cb775-ff4f-48be-aad2-c8ae7e0224d1
Bannon, Paul G.
4f5e7182-7346-4f4e-810a-ab34a1b96f4b
Ohri, Sunil K.
8aa5698c-78cf-4f59-a5af-5afa46f0348c
Haw, Marcus P.
de1cf3ff-7184-4e05-af6b-5a90085a8eba
Bayfield, Matthew S.
a3ce0ced-6488-4b3c-8f90-edae9463a75c
Hendel, Nick P.
d0115d1e-a8e4-4bdb-a9ff-4c37b5919db2
Livesey, Steven A.
c5d8a3d1-266b-41a4-9165-77c02e13bc6f
Hughes, Clifford F.
256714a8-a89a-4bc5-9bbb-a74cb867a421
Monro, James L.
68cc1066-fb7a-42cb-8d14-d92ee8680ce9

Dalrymple-Hay, Malcolm J.R., Crook, Timothy, Bannon, Paul G., Ohri, Sunil K., Haw, Marcus P., Bayfield, Matthew S., Hendel, Nick P., Livesey, Steven A., Hughes, Clifford F. and Monro, James L. (2002) Risk of reoperation for structural failure of aortic and mitral tissue valves. The Journal of Heart Valve Disease, 11 (3), 419-423.

Record type: Article

Abstract

In order to assess the risk of reoperation in the case of a failing stented tissue valve, 259 patients (118 males, 141 females; mean age 60.1 ± 15.4 years) underwent redo valve replacement. Of these patients, 94 (36.3%) underwent redo aortic valve replacement (AVR), 105 (40.5%) redo mitral valve replacement (MVR), and 60 (23.2%) redo aortic and mitral valve replacement (DVR). Twenty patients (7.7%) had previous coronary artery bypass grafting (CABG); further CABG were performed in 32 cases (12.4%). Preoperatively, 216 patients (83.3%) were in NYHA functional class III or IV. Early mortality was (6.5%; n = 17). A higher preoperative NHYA status (p <0.0004) and emergency surgery (p <0.0001) were associated with an increased risk of operative death. Age at operation (p = 0.45), previous CABG (p = 0.45), position of the valve replaced (p = 0.2), type of implant (p = 0.06) and presence of coronary artery disease (p = 0.51) were not associated with a significant risk of operative mortality. A failing tissue valve may be replaced, with acceptable operative mortality and morbidity. The trend towards reducing the age at which tissue valve implantation is performed may be justified.

Full text not available from this repository.

More information

Published date: 2002

Identifiers

Local EPrints ID: 25966
URI: http://eprints.soton.ac.uk/id/eprint/25966
ISSN: 0966-8519
PURE UUID: 1d47e944-2fa2-41bb-8e6a-28d0b04f6bd4

Catalogue record

Date deposited: 11 Apr 2006
Last modified: 15 Jul 2019 19:15

Export record

Contributors

Author: Malcolm J.R. Dalrymple-Hay
Author: Timothy Crook
Author: Paul G. Bannon
Author: Sunil K. Ohri
Author: Marcus P. Haw
Author: Matthew S. Bayfield
Author: Nick P. Hendel
Author: Steven A. Livesey
Author: Clifford F. Hughes
Author: James L. Monro

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×